Resveratrol as a Protective Molecule for Neuroinflammation: A Review of Mechanisms

ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)


Volume 17, 15 Issues, 2016


Download PDF Flyer




Current Pharmaceutical Biotechnology

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 152nd of 255 in Pharmacology & Pharmacy
  • 213th of 290 in Biochemistry & Molecular Biology

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Zeno Foldes-Papp
Christian Clinical Center Siegen-Kreuztal
Siegen-Kreuztal
Germany


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.95
5 - Year: 2.558

Resveratrol as a Protective Molecule for Neuroinflammation: A Review of Mechanisms



Current Pharmaceutical Biotechnology, 15(4): 318-329.

Author(s): Justine Renaud and Maria-Grazia Martinoli.

Affiliation: Department of Medical Biology, C.P. 500, U.Q.T.R., Trois-Rivières, Qc., G9A 5H7, Canada.

Abstract

Under normal conditions, most of the central nervous system (CNS) is protected by the blood brain barrier (BBB) from systemic inflammation progression and from the infiltration of immune cells. As a consequence, the CNS developed an original way to provide surveillance, defense and repair, which relies on the complex process of neuroinflammation. Despite tight regulation, neuroinflammation is frequently the cause of irreversible nerve cell loss but it is also where the solution lies. Specific immune crosstalk taking place in the CNS needs to be decoded in order to identify the best therapeutic strategies aimed at helping the CNS restore homeostasis in difficult conditions such as in neurodegenerative disorders. This review deals with the double-edged sword nature of neuroinflammation and the use of resveratrol in various models as one of the most promising therapeutic molecules for preventing the consequences of nerve cell autodestruction.

Keywords:

Microglia, neurodegeneration, neuroinflammation, neuroprotection, polyphenols, resveratrol.



Purchase Online Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 15
Issue Number: 4
First Page: 318
Last Page: 329
Page Count: 12
DOI: 10.2174/1389201015666140617101332
Advertisement
Global Biotechnology Congress 2016Drug Discovery and Therapy World Congress 2016

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science